Bacteriological and molecular characterization of temperature- and CO2-dependent Streptococcus pneumoniae serotype

Jun Kobayashi1,2, Misako Ohkusu3, Takehisa Matsumoto4

  • 1Department of Laboratory Medicine, Nagano Children's Hospital , Azumino, Japan.

Microbiology Spectrum
|October 12, 2023
PubMed
Abstract

Insights

Streptococcus pneumoniae 24F ST162 isolates from Japanese children with invasive pneumococcal disease (IPD) exhibit poor growth in ambient air. This presents challenges for antimicrobial susceptibility testing and diagnosis.

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Vaccinology

Background:

  • Invasive pneumococcal disease (IPD) remains a significant global health concern.
  • Streptococcus pneumoniae serotype 24F, particularly sequence type (ST) 162, has emerged as a notable pathogen.
  • The 13-valent pneumococcal conjugate vaccine (PCV13) has altered the epidemiological landscape of IPD.

Purpose of the Study:

  • To characterize Streptococcus pneumoniae serotype 24F ST162 isolates from Japanese children with IPD.
  • To investigate the growth characteristics and antimicrobial susceptibility testing challenges associated with this specific isolate.
  • To inform clinical practice and future strategies in the post-PCV13 era.

Main Methods:

  • Isolation and characterization of Streptococcus pneumoniae serotype 24F ST162 from pediatric IPD cases.
  • Assessment of bacterial growth under standard laboratory conditions (35°C in ambient air).
  • Evaluation of implications for antimicrobial susceptibility testing methodologies.

Main Results:

  • Serotype 24F ST162 isolates demonstrated impaired growth at 35°C in ambient air.
  • Standard broth microdilution antimicrobial susceptibility testing is not feasible under ambient air conditions for these isolates.
  • This presents a diagnostic and therapeutic challenge for clinicians and laboratories.

Conclusions:

  • Serotype 24F ST162 possesses unique bacteriological characteristics that impact standard laboratory diagnostics.
  • Awareness of these traits is crucial for accurate diagnosis and effective treatment of IPD caused by this serotype.
  • This serotype may pose an increasing challenge in the post-PCV13 vaccination era.